Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-Up

Marco Denina1, Giulia Pruccoli1, Carlo Scolfaro1

  • 1From the Department of Pediatrics, Infectious Diseases Unit.

Insights

Sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children are not well understood. A 4-month follow-up of 25 children hospitalized with COVID-19 found rare mid-term sequelae, suggesting a favorable prognosis.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • The long-term effects of SARS-CoV-2 infection in pediatric populations remain largely unknown.
  • Understanding post-COVID-19 conditions in children is crucial for clinical management and public health strategies.

Purpose of the Study:

  • To investigate the mid-term clinical, laboratory, and imaging sequelae in children previously hospitalized with COVID-19.
  • To assess the frequency and nature of any persistent symptoms or complications.

Main Methods:

  • A cohort of 25 children hospitalized for COVID-19 was prospectively followed for 4 months.
  • Evaluations included clinical assessments, laboratory tests, and lung ultrasound imaging.
  • Data analysis focused on identifying any residual health issues.

Main Results:

  • Mid-term sequelae were infrequently observed in the studied cohort of children.
  • The majority of children showed no significant clinical, laboratory, or lung ultrasound abnormalities at follow-up.
  • This suggests a generally good recovery trajectory for most pediatric COVID-19 patients.

Conclusions:

  • Hospitalized children with COVID-19 appear to have a low incidence of mid-term sequelae.
  • Further research is warranted to confirm these findings in larger, diverse pediatric cohorts.
  • The study provides preliminary evidence for a favorable prognosis following severe acute respiratory syndrome coronavirus 2 infection in children.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
670
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
632
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
840
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K